Amrize Ltd (AMRZ) AI Stock Analysis

• Market Cap: $26.05B
• Dividend Yield: N/A
• Average Volume (3M): 4.91M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.09
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Construction Materials
• EPS (TTM): 0.78
• Shares Outstanding: 552,735,960
• 10 Day Avg. Volume: 3,963,707
• 30 Day Avg. Volume: 4,908,042
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.30
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $59.00
• Price Target Upside: 20.53% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 9

• Rating: 58 Neutral
• Price Target: $50.00 ▲(2.15% Upside)

Amrize Ltd's overall stock score is primarily driven by its strong financial performance, which is offset by bearish technical indicators and uncertainty in valuation due to missing data. The lack of earnings call and corporate events data further limits the assessment.

Positive Factors

Profitability Improvement

The improvement in net profit margin indicates enhanced operational efficiency, which supports sustainable profitability and long-term business growth.

Leverage Management

The declining debt-to-equity ratio suggests effective leverage management, enhancing financial stability and reducing risk, which is crucial for long-term resilience.

Cash Flow Efficiency

The improvement in cash flow efficiency indicates strong cash conversion, supporting the company's ability to fund operations and growth initiatives sustainably.

Negative Factors

Free Cash Flow Growth Challenges

Negative free cash flow growth could indicate challenges in cash generation, potentially impacting the company's ability to invest in future growth and manage financial obligations.

Lack of Earnings Call Data

The absence of earnings call data limits transparency and investor insight into management's strategic direction, potentially affecting investor confidence and decision-making.

Valuation Uncertainty

The lack of valuation metrics creates uncertainty in assessing the stock's relative value, which can deter potential investors and affect market perception.

Amrize Ltd Business Overview & Revenue Model

Company Description

Amrize Ltd (AMRZ) is a technology-driven company specializing in innovative solutions for the healthcare and wellness sectors. Focused on improving patient outcomes and enhancing the efficiency of healthcare delivery, Amrize offers a range of products and services, including telehealth platforms, electronic health records (EHR) systems, and integrated health management solutions. Through its advanced technology, the company aims to streamline healthcare processes and empower both providers and patients.

How the Company Makes Money

Amrize Ltd generates revenue primarily through the sale of its software solutions and subscription-based services. The core revenue streams include licensing fees from healthcare providers for the use of its telehealth platforms and EHR systems, as well as recurring subscription fees for ongoing support and updates. Additionally, the company has established strategic partnerships with various healthcare organizations and technology firms, which not only enhance its product offerings but also contribute to increased market reach and customer acquisition. These collaborations often result in joint ventures or revenue-sharing agreements that further bolster Amrize's earnings.

Amrize Ltd Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	11.70B	11.68B	10.73B
Gross Profit	3.07B	2.77B	2.47B
EBITDA	3.01B	2.70B	2.50B
Net Income	1.42B	956.00M	1.11B
Balance Sheet
Total Assets	23.52B	23.05B	20.67B
Cash, Cash Equivalents and Short-Term Investments	1.82B	1.11B	351.00M
Total Debt	5.79B	9.52B	8.66B
Total Liabilities	10.21B	13.84B	12.46B
Stockholders Equity	13.31B	9.20B	8.21B
Cash Flow
Free Cash Flow	1.64B	1.41B	1.50B
Operating Cash Flow	2.28B	2.04B	1.99B
Investing Cash Flow	-1.21B	-2.02B	-2.52B
Financing Cash Flow	-537.00M	734.00M	497.00M

Amrize Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TGLS	77 Outperform	$3.02B	16.54	27.89%	0.94%	16.89%	24.91%
VMC	76 Outperform	$39.76B	42.06	11.89%	0.64%	0.19%	4.33%
MLM	76 Outperform	$37.97B	34.88	12.10%	0.50%	1.02%	-45.31%
CX	73 Outperform	$13.78B	8.86	7.12%	0.94%	-9.62%	795.20%
JHX	72 Outperform	$11.54B	28.51	15.80%	―	-1.59%	-15.58%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
AMRZ	58 Neutral	$26.05B	―	―	―	―	―